Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,727,155
+$119,028 QoQ
Shares Held
21,223
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#1,396
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Montecito Bank & Trust holds $27,844,791 across 8 Drug Manufacturers - General names. MRK ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,044 | $10,847,645 | |
| 2 | ABBV |
AbbVie Inc.
|
29,468 | $7,415,326 | |
| 3 | JNJ |
Johnson & Johnson
|
17,089 | $4,340,092 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
21,223 | $2,727,155 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,872 | $868,208 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,596 | $725,780 | |
| 7 | PFE |
Pfizer Inc
|
26,984 | $649,773 | |
| 8 | NVS |
Novartis AG
|
1,728 | $270,812 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,727,155 | 21,223 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,608,127 | 21,682 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $2,393,191 | 22,736 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $2,293,722 | 27,329 | Shares | Defined | 2025-10-07 | |
| 2025-03-31 | $2,685,259 | 29,916 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $2,943,811 | 29,592 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $3,089,513 | 27,206 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $2,711,714 | 21,904 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,747,198 | 20,820 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $2,148,020 | 19,703 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $1,966,962 | 19,106 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,151,100 | 18,642 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,066,200 | 19,421 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,178,946 | 19,639 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,735,317 | 20,150 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,741,620 | 19,103 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,567,892 | 19,109 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,494,173 | 19,496 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,475,685 | 19,647 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,524,291 | 19,600 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $1,466,174 | 19,019 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,455,956 | 17,799 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,479,496 | 17,836 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,367,504 | 17,684 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,326,829 | 17,245 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||